News Trends, News Analysis, News Archive.



Related Articles

entertainmentNews reuters.com

'Shape of Water' leads Globes nominees; risk-takers rewarded

LOS ANGELES (Reuters) - Hollywood's long awards season began to take shape on Monday with Golden Globe nominations that rewarded risk-taking and shone a spotlight on veterans and newcomers alike.

politicsNews reuters.com

Women accusing Trump of sexual misconduct seek congressional probe

NEW YORK (Reuters) - Three women who have accused U.S. President Donald Trump of sexual misconduct called on Monday for a congressional investigation into his behavior amid a wave of similar accusations against prominent men in Hollywood, the media and politics.

cnn.com

Trump's 12 Diet Cokes-a-day habit is risky

President Donald Trump downs a dozen Diet Cokes each day, The New York Times reported this weekend. His love of the bubbly beverage is shared by many Americans and at least one of his predecessors. President Bill Clinton was frequently photographed with a can in his hand and reportedly placed a Diet Coke -- along with a now-outdated cell phone and other items -- in a time capsule at his official presidential library.

healthNews reuters.com

Commuters often exposed to damaging noise levels

(Reuters Health) - Loud noise exceeding levels that can damage hearing is regularly encountered by commuters using buses, subways and even biking, a Canadian study suggests.

healthNews reuters.com

Kids continue to die in window-blind accidents, despite safety warnings

(Reuters Health) - Even though window coverings have been recognized for decades as a safety hazard to children, injuries from blinds and shades still send many kids to the emergency room each year, a U.S. study suggests.

healthNews reuters.com

FDA OKs Sanofi's follow-on biologic of Lilly's diabetes drug Humalog

(Reuters) - The U.S. Food and Drug Administration said on Monday it approved Sanofi SA's Admelog as the first follow-on biologic version of Eli Lilly and Co's fast-acting insulin, Humalog.

healthNews reuters.com

Austria to drop impending smoking ban, bucking Western trend

VIENNA (Reuters) - While much of the West has barred smoking in restaurants and bars, Austria's impending ban is set to be stubbed out.

healthNews reuters.com

Opioid painkiller prescriptions may run in families

Reuters Health - When one person in a household gets prescribed opioids, the other people who live with them are more likely to get their own prescriptions for these narcotic painkillers, a U.S. study suggests.

cnn.com

Women detail sexual allegations against Trump

A group of women who have publicly accused President Donald Trump of sexual harassment and assault will detail their accounts of being groped, fondled and forcibly kissed by the businessman-turned-politician at a news conference on Monday.

healthNews reuters.com

'Ground-breaking' new drug gives hope in Huntington's disease

LONDON (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntington's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.

companyNews reuters.com

BRIEF-Anthera Pharmaceuticals Announces Positive Outcome In The Phase 3 Result Clinical Study Of Sollpura

* ANTHERA PHARMACEUTICALS ANNOUNCES POSITIVE OUTCOME OF INTERIM FUTILITY ANALYSIS IN THE PHASE 3 RESULT CLINICAL STUDY OF SOLLPURA

healthNews reuters.com

'Ground-breaking' new drug gives hope on Huntingdon's disease

LONDON (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntingdon's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.

companyNews reuters.com

BRIEF-Affimed presents data from Phase 1B combination study of AFM13 with pembrolizumab at Ash

* Affimed presents data from Phase 1B combination study of AFM13 with Pembrolizumab at Ash

healthNews reuters.com

Indonesia races to contain diphtheria outbreak ahead of 2018 Asian Games

JAKARTA (Reuters) - Health authorities in Jakarta kicked off a special immunization program on Monday to rein in an "extraordinary" outbreak of diphtheria that has sparked concerns about the Indonesian capital’s readiness to host the Asian Games next June. Diphtheria cases have spiked 42 percent since last year, health officials say, with at least 32 deaths and more than 590 cases recorded across the archipelago, the bulk of them in densely populated Jakarta and neighboring provinces.

healthNews reuters.com

GSK's new pharma head on lookout for cancer deals to boost pipeline

LONDON (Reuters) - GlaxoSmithKline will scout for deal opportunities in cancer medicine, as well as immunology, as the drugmaker seeks to rebuild its presence in oncology, its new head of pharmaceuticals told Reuters.

topNews reuters.com

Situation on Korean Peninsula risks moving into 'hot phase': Ifax cites Russian foreign minister

MOSCOW (Reuters) - The situation on the Korean Peninsula risks to move into a "hot phase", Russian Foreign Minister Sergei Lavrov warned on Monday, the Interfax news agency reported.

companyNews reuters.com

BRIEF-Boudewijn Duinstra Named Head Of First Line Clearing Risk, ICE Clear Europe

* INTERCONTINENTAL EXCHANGE APPOINTS BOUDEWIJN DUINSTRA AS HEAD OF FIRST LINE CLEARING RISK FOR ICE CLEAR EUROPE

healthNews reuters.com

Roche: Tecentriq cocktail slows kidney cancer progression

ZURICH (Reuters) - Combining Roche's Tecentriq immunotherapy with its older drug Avastin reduced the risk of disease worsening or death (PFS) for the initial treatment of advanced kidney cancer in some patients, the Swiss drugmaker said on Monday

companyNews reuters.com

UPDATE 1-Roche: Tecentriq cocktail slows kidney cancer progression

ZURICH, Dec 11 (Reuters) - Combining Roche's Tecentriq immunotherapy with its older drug Avastin reduced the risk of disease worsening or death (PFS) for the initial treatment of advanced kidney cancer in some patients, the Swiss drugmaker said on Monday

healthNews reuters.com

Merck raises stakes in lung cancer as rivals close in

LOS ANGELES (Reuters) - Merck & Co Inc, maker of the only immunotherapy approved for patients newly-diagnosed with the most common type of lung cancer, could solidify its lead by playing the long game, even as rivals edge closer.

Hurricane Maria (2017) nytimes.com

Lives at Risk Inside a Senior Complex in Puerto Rico With No Power

Conditions at the largest housing project for low-income seniors on the hurricane-ravaged island illustrate a health crisis for the most vulnerable.

companyNews reuters.com

UPDATE 1-Novartis CAR-T therapy leads to durable response in lymphoma study

Dec 10 (Reuters) - Patients with an advanced form of an aggressive blood cancer who had initially responded to Novartis' new type of gene-modifying immunotherapy continued to respond at least six months after treatment, according to updated data released at a medical meeting on Sunday.

companyNews reuters.com

BRIEF-‍Verastem Announces Clinical Data From Pivotal Phase 3 Duo Study​

* ‍VERASTEM ANNOUNCES CLINICAL DATA FROM PIVOTAL PHASE 3 DUO™ STUDY​

healthNews reuters.com

Hospital operators in merger talks to form U.S. industry leader: WSJ

NEW YORK (Reuters) - Ascension Health and Providence St. Joseph Health are in talks about a merger between the two Catholic non-profits that would create the largest U.S. hospital chain, the Wall Street Journal reported on Sunday, citing people familiar with the discussions.

Haley, Nikki R nytimes.com

Nikki Haley Says Women Who Accuse Trump of Misconduct ‘Should Be Heard’

The comments by Ms. Haley, the United Nations ambassador, were a break from the administration’s assertions that the allegations have no merit and should be dismissed.

healthNews reuters.com

Hospital operators in merger talks to create U.S. industry leader: WSJ

NEW YORK (Reuters) - Ascension Health and Providence St. Joseph Health are in discussions about a merger that would create the largest hospital chain in the United States, the Wall Street Journal reported on Sunday, citing people familiar with the situation.

healthNews reuters.com

Exclusive: Philippines defied experts' advice in pursuing dengue immunization program

MANILA (Reuters) - As she announced in January 2016 that the Philippines would immunize one million children with a new dengue vaccine, the nation's then health secretary Janette Garin boasted it was a world-first and a tribute to her country's "expertise" in research.

Women and Girls nytimes.com

Harassment All Around, Afghan Women Weigh Risks of Speaking Out

Watching the “Me, Too” campaign, some Afghan woman are more willing to talk about assaults. But the danger to their lives if they do has not diminished.

Pop and Rock Music nytimes.com

Review: Taylor Swift Leads a Jingle Ball Full of Hardheaded Women and Nice Guys

The annual concert of hitmakers at Madison Square Garden slighted pop’s diversity, offering a narrow definition of what “hit radio” looked like in 2017.

healthNews reuters.com

France orders international recall of Lactalis baby formula

PARIS (Reuters) - France has ordered banned the sale and ordered a recall of several baby formula milk and baby food products made by French dairy giant Lactalis after the discovery of salmonella bacteria, consumer protection agency DGCCRF said in a statement.

healthNews reuters.com

Gilead's new drug keeps 56 percent of lymphoma trial patients alive

(Reuters) - More than half of trial patients with an advanced, aggressive form of blood cancer lived for at least a year after one-time treatment with Yescarta, a novel therapy sold by Gilead Sciences Inc, according to study results presented on Sunday.

companyNews reuters.com

'Unheard of' responses to bluebird CAR-T therapy seen in myeloma study

Dec 10 (Reuters) - More than half of patients with advanced multiple myeloma who had run out of therapeutic options remained in complete remission after receiving bluebird bio Inc's experimental gene-modifying immunotherapy in a small, early stage study, according to updated data released on Sunday.

companyNews reuters.com

Novartis CAR-T therapy leads to durable response in lymphoma study

Dec 10 (Reuters) - Patients with an advanced form of an aggressive blood cancer who had initially responded to Novartis' new type of gene-modifying immunotherapy continued to respond at least six months after treatment, according to updated data released at a medical meeting on Sunday.

politicsNews reuters.com

Haley: Women accusers should be heard, even if Trump is target

WASHINGTON (Reuters) - U.N. Ambassador Nikki Haley said on Sunday she believes any woman who has felt violated or mistreated by a man has every right to speak up, even if it is President Donald Trump they are accusing.

healthNews reuters.com

Roche lymphoma drug drives high remission rate, longer survival: study

(Reuters) - An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment alone, according to data from a mid-stage trial released at a medical meeting on Sunday.

companyNews reuters.com

Roche lymphoma drug drives high remission rate, longer survival-study

Dec 10 (Reuters) - An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment alone, according to data from a mid-stage trial released at a medical meeting on Sunday.

Cancer nytimes.com

Caring for a Son With Cancer, and for Herself

Andrew gave his mother, Regina Hensley, a reason to live. We follow the pair as she fights a history of addiction and he fights an aggressive form of cancer.

Sexual Harassment nytimes.com

In Indonesia, Women Begin to Fight ‘Epidemic’ of Street Harassment

Activist groups are springing up, and the first step, they say, is exposing the routine instances of groping and catcalling that have long gone unreported.

topNews reuters.com

U.N. envoy told North Korea urgent need to open channels to cut conflict risk

SEOUL/UNITED NATIONS (Reuters) - The United Nations political affairs chief told senior North Korean officials during a visit to Pyongyang this week that there was an "urgent need to prevent miscalculations and open channels to reduce the risks of conflict," the world body said.

healthNews reuters.com

U.S. House committee 'may reconsider' WHO cancer agency funds

LONDON (Reuters) - U.S. congressional committee members warned on Friday that Washington's funding of the World Health Organization's cancer research agency could be halted unless it is more open about its operations.

healthNews reuters.com

Lilly's stomach cancer drug meets main goal, but fails to improve survival rate

(Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a gastric cancer treatment met the main goal of preventing the disease from advancing, but failed its secondary target of improving overall survival rates.

companyNews reuters.com

UPDATE 1-Lilly's stomach cancer drug meets main goal, but fails to improve survival rate

Dec 8 (Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a gastric cancer treatment met the main goal of preventing the disease from advancing, but failed its secondary target of improving overall survival rates.

companyNews reuters.com

REFILE-Lilly's Cyramza meets main goal in gastric cancer study

Dec 8 (Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a treatment for a type of gastric cancer met its main goal of preventing the disease from advancing.

companyNews reuters.com

BRIEF-Lilly's Cyramza meets Primary Endpoint in gastric cancer study

* LILLY REPORTS TOP-LINE RESULTS FROM CYRAMZA® (RAMUCIRUMAB) PHASE 3 STUDY IN FIRST-LINE ADVANCED GASTRIC CANCER

healthNews reuters.com

Lilly's Cyramza meets main goal in gastric cancer study

(Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a treatment for a type of gastric cancer met its main goal of preventing the disease from advancing.

healthNews reuters.com

Depression in late teens linked to high school drop out

(Reuters Health) - Older teens struggling with depression are more than twice as likely to drop out of high school as peers without that mental illness or those who recovered from a bout of depression earlier in life, Canadian researchers say.

Women and Girls nytimes.com

Opinion: My Generation Thought Women Were Empowered. Did We Deceive Ourselves?

Rethinking a lifetime of sexism in the #MeToo moment.

healthNews reuters.com

Kids who get moving may also get better grades

(Reuters Health) - Students who get extra physical activity may pay more attention in school and do better in subjects like reading and math, a research review suggests.

healthNews reuters.com

Acupressure app may help ease menstrual cramp pain

(Reuters Health) - Women with intense menstrual cramp pain may get more relief from smartphone app-guided acupressure than with typical medical treatments like painkillers, a recent study suggests.

sportsNews reuters.com

Alpine skiing: Vonn's stock is sky high in the risk business

LAKE LOUISE, Alberta (Reuters) - The downhill is very much a high risk, high reward business and American speed queen Lindsey Vonn was reminded again of the price you pay for success on the alpine World Cup ski circuit.

sportsNews reuters.com

Alpine skiing: Women's combined called off due to fog

ST MORITZ, Switzerland (Reuters) - The opening women's combined race of the World Cup season was called off after the first of the two legs on Friday because of fog.

Colleges and Universities nytimes.com

At Columbia, Three Women, 30 Years and a Pattern of Harassment

Former graduate students say over decades the same professor made sexual advances toward them, and their reactions illustrate changing norms on campus.

healthNews reuters.com

Credibility, recipes, references help food blogs improve eating habits

(Reuters Health) - Consumers like healthy eating blogs written by nutritionists who seem credible and who interact with their readers, a small study in Canada suggests.

healthNews reuters.com

Uganda says it has contained an outbreak of Marburg hemorrhagic fever

KAMPALA (Reuters) - Uganda said on Friday it had successfully contained an outbreak of the Marburg virus, a highly infectious haemorrhagic fever announced by officials on Oct. 19, which killed three people.

healthNews reuters.com

Pfizer breast cancer drug superior to chemotherapy in late stage study

(Reuters) - Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday.

companyNews reuters.com

Pfizer breast cancer drug superior to chemotherapy in Phase III study

Dec 8 (Reuters) - Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday.

healthNews reuters.com

Top Russian pork producer Miratorg reports ASF outbreak

MOSCOW (Reuters) - Russia's largest pork producer Miratorg on Friday reported an outbreak of African Swine Fever (ASF) at one of its sites in the Belgorod region in central Russia.

businessNews reuters.com

Roche, Novartis' Italian heads risk trial for alleged market rigging: sources

ROME (Reuters) - The local heads of Swiss drugmakers Roche and Novartis risk facing trial in Italy for alleged market manipulation, judicial sources said on Friday.

worldNews reuters.com

Venice Commission: Polish judiciary reforms pose a serious risk

WARSAW (Reuters) - The Venice Commission, a panel of constitutional law experts of the human rights body Council of Europe, said on Friday that Poland's proposed court overhaul poses serious risks to all parts of the country's judiciary.

healthNews reuters.com

Venezuela's chronic shortages give rise to 'medical flea markets'

SAN CRISTOBAL/MARACAIBO, Venezuela (Reuters) - Venezuela's critical medicine shortage has spurred "medical flea markets," where peddlers offer everything from antibiotics to contraceptives laid out among the traditional fruits and vegetables.

healthNews reuters.com

Russia's meat firm Miratorg reports ASF outbreak at 1 site in Russia

MOSCOW (Reuters) - Russian privately-owned meat producer Miratorg said on Friday there was an outbreak of African Swine Fever (ASF) at one of its sites in Russia's Belgorod region.

healthNews reuters.com

Philippines to seek refund of $59 million from Sanofi amid vaccine risk

MANILA (Reuters) - The Philippines will seek the return of 3 billion pesos ($59 million) it paid French drugmaker Sanofi for a dengue vaccine used to immunize hundreds of thousands of children that Sanofi has said could worsen the disease in some cases.

healthNews reuters.com

Roche study finds cancer 'Velcro' that halts T-cell attack

ZURICH (Reuters) - Scientists at Swiss drugmaker Roche said on Friday they may have discovered why some tumors resist new immunotherapy drugs as well as a possible means of turning the tables to incite a T-cell attack.

healthNews reuters.com

U.S. Department of Justice investigating fetal tissue transfers

(Reuters) - The U.S. Department of Justice asked on Thursday for documents related to a Senate committee's report on the transfer of fetal tissue by abortion provider Planned Parenthood, according to a letter seen by Reuters.

healthNews reuters.com

U.S. Department of Justice seeks documents on fetal tissue transfers

(Reuters) - The U.S. Department of Justice sent a letter on Thursday, seen by Reuters, seeking documents related to a Senate committee's report on the transfer of fetal tissue by abortion provider Planned Parenthood.

healthNews reuters.com

Antibiotics sales for use in U.S. farm animals dropped in 2016: FDA

CHICAGO (Reuters) - The sale and distribution of antibiotics approved for use in food-producing animals in the United States decreased by 10 percent from 2015 to 2016, a U.S. Food and Drug Administration (FDA) report said on Thursday.

cnn.com

Analysis: WH says the election ended debate on Trump's treatment of women. Not exactly.

On Thursday afternoon, White House press secretary Sarah Sanders was asked about Al Franken's description of President Donald Trump as "a man who has bragged on tape about his history of sexual assault."

healthNews reuters.com

Childhood cancer survivors have more blood pressure problems

(Reuters Health) - More than one in 12 adult survivors of childhood cancers may have undiagnosed high blood pressure, a U.S. study suggests.

healthNews reuters.com

Faulty positioning in rugby tackles boosts injury risk

(Reuters Health) - Head, neck and shoulder injuries during rugby tackles are more common when the tackler’s head is incorrectly positioned in relation to the ball carrier, a small study has found.

companyNews reuters.com

GLOBAL MARKETS-Stocks gain as risk appetite returns; oil rebounds

* Bitcoin tops $15,000, continues surge (Updates with afternoon trading)

companyNews reuters.com

BRIEF-Celgene Reports Long-Term Efficacy Data From Phase III Geparsepto Study

* LONG-TERM EFFICACY DATA FROM THE PHASE III GEPARSEPTO STUDY IN HIGH RISK EARLY BREAST CANCER PATIENTS TREATED WITH ABRAXANE VS. SOLVENT-BASED PACLITAXEL TO BE REPORTED

healthNews reuters.com

Gum infections tied to increased risk of stomach cancer precursor

(Reuters Health) - Gum infections may increase people’s risk for sores in the digestive tract that can lead to stomach cancer, a small study suggests.

cnn.com

Pollution putting infants at risk of brain damage

Almost 17 million infants worldwide are breathing toxic air, potentially affecting their brain development, according to a UNICEF report published Wednesday.

healthNews reuters.com

Open windows and doors can improve sleep quality

(Reuters Health) - Leaving a bedroom door or window open may help people sleep better, a study from the Netherlands suggests.

companyNews reuters.com

GLOBAL MARKETS-Stocks gain, dollar hits two-week high as risk appetite returns

* Bitcoin tops $15,000, continues surge (Updates with open of U.S. markets; changes dateline from London)

healthNews reuters.com

Sage shares surge as depression drug succeeds in mid-stage trial

(Reuters) - Drug developer Sage Therapeutics Inc's shares soared as much as 85 percent to a record high on Thursday after its experimental drug to reduce the symptoms of depression succeeded in a mid-stage trial.

companyNews reuters.com

UPDATE 5-Roche drug cocktail doubles chance of holding lung cancer at bay

* Analysts see drug sales topping $4.6 bln by 2023 - poll (Adds analyst comment)

Florence (Italy) nytimes.com

Florence Journal: ‘Taxi Therapy’ for Young Cancer Patients in Italy

In Florence, Caterina Bellandi, or Zia Caterina, gives free rides and adds a colorful note to the lives of children battling cancer.

healthNews reuters.com

South African egg prices seen rising 20 percent after avian flu outbreak

JOHANNESBURG (Reuters) - Egg prices in South Africa are expected to increase by as much as 20 percent after an outbreak of the highly pathogenic avian flu in June forced farmers to cull egg laying birds, industry experts said on Thursday.

healthNews reuters.com

More than 2,000 drugs now in cancer immunotherapy race

LONDON (Reuters) - The race to develop new immunotherapy treatments against cancer has sparked an unprecedented explosion in the oncology drug pipeline, with more than 2,000 immune system-boosting agents now in development.

cnn.com

Hormonal birth control increases breast cancer risk

Birth control can increase a woman's risk of breast cancer by up to 38%, depending on how long she has taken it, a new study finds.

Women and Girls nytimes.com

Being a Doctor Is Hard. It’s Harder for Women.

Female medical residents and physicians endure bias and a larger burden with home duties. They also face a greater risk of depression.

worldNews reuters.com

Lebanon emerges from crisis with Iran on top, but risks remain

BEIRUT (Reuters) - Iran's allies in Lebanon have emerged even stronger from a crisis triggered by Saudi Arabia, which achieved little more than to force the Saudis' main Lebanese ally - Prime Minister Saad al-Hariri - closer to Tehran's friends in Beirut.

healthNews reuters.com

Sage shares surge as depression drug succeeds mid-stage trial

(Reuters) - Sage Therapeutics Inc's shares surged more than 63 percent premarket on Thursday, on track to add about $2.5 billion to the company's market value, after its drug succeeded in reducing the symptoms of depression in a mid-stage trial.

companyNews reuters.com

BRIEF-Kalytera Therapeutics Says ‍Results Of Phase 2 Clinical Study In Prevention Of Graft Versus Host Disease​ Are Expected By Q3 2018

* KALYTERA ANNOUNCES INITIATION OF PHASE 2 CLINICAL STUDY IN PREVENTION OF GRAFT VERSUS HOST DISEASE AND AGREEMENT WITH THE SALZMAN GROUP OF ISRAEL TO MANAGE AND PARTIALLY FUND THE STUDY TO BE LED BY A WORLD CLASS TEAM

companyNews reuters.com

BRIEF-Pieris Pharma Received Clearance to Initiate Its First-In-Human Study In Australia For PRS-060/AZD1402

* PIERIS PHARMACEUTICALS - RECEIVED ETHICS AND REGULATORY CLEARANCE TO INITIATE ITS FIRST-IN-HUMAN STUDY IN AUSTRALIA FOR PRS-060/AZD1402

worldNews reuters.com

Hungary's Jobbik party says fine risks making it insolvent ahead of 2018 vote

BUDAPEST (Reuters) - Hungary's main opposition party would be unable to compete at an election next April if state auditors impose a heavy fine in a campaign finance case, a vice chairman for the nationalist Jobbik party told Reuters on Thursday.

companyNews reuters.com

GLOBAL MARKETS-Dollar hits two-week high, world shares climb as risk appetite returns

LONDON, Dec 7 (Reuters) - The dollar rose to its highest level in two weeks on Thursday and world shares rebounded amid a broader recovery in global risk sentiment.

healthNews reuters.com

Sage's depression drug succeeds in mid-stage study, shares soar

(Reuters) - Sage Therapeutics Inc said on Thursday its drug to treat patients with moderate to severe depression met the main goal of reducing symptoms in a mid-stage study, sending its shares soaring 52.3 percent in premarket trading.

companyNews reuters.com

UPDATE 1-Sage's depression drug succeeds in mid-stage study, shares soar

Dec 7 (Reuters) - Sage Therapeutics Inc said on Thursday its drug to treat patients with moderate to severe depression met the main goal of reducing symptoms in a mid-stage study, sending its shares soaring 52.3 percent in premarket trading.

healthNews reuters.com

Indonesia fights 'extraordinary' diphtheria outbreak that has killed 32

JAKARTA (Reuters) - Indonesian health authorities will launch an immunization drive next week to contain a sharp rise in cases of diphtheria, which has killed at least 32 people, including many children, in the world's fourth most populous country this year.

companyNews reuters.com

UPDATE 3-Roche drug cocktail doubles chance of holding lung cancer at bay

* Tecentriq drug cocktail cuts risk of disease progressing by 38 pct

companyNews reuters.com

UPDATE 2-Roche drug cocktail doubles chance of holding lung cancer at bay

* Tecentriq drug cocktail cuts risk of disease progressing by 38 pct

businessNews reuters.com

Asia shares creep above 2-month lows, but growth, U.S. policy risks weigh

TOKYO (Reuters) - Asian shares hovered above two-month lows on Thursday as some high-tech bellwethers bounced back after a searing sell-off although softer oil and copper prices and uncertainty over U.S. policy kept many investors cautious.

companyNews reuters.com

GLOBAL MARKETS-Asia shares creep above 2-mth lows, but growth, US policy risks weigh

TOKYO, Dec 7 (Reuters) - Asian shares hovered above two-month lows on Thursday as some high-tech bellwethers bounced back after a searing sell-off although softer oil and copper prices and uncertainty over U.S. policy kept many investors cautious.

companyNews reuters.com

UPDATE 1-Roche drug cocktail doubles chance of holding lung cancer at bay

ZURICH, Dec 7 (Reuters) - Adding Roche's immunotherapy Tecentriq to older drugs doubled the percentage of lung cancer patients who survived a year without their disease advancing, an outcome some experts labeled unprecedented.

companyNews reuters.com

South Africa rand edges down as global risk appetite wanes

JOHANNESBURG, Dec 7 (Reuters) - The South African rand weakened on Thursday, as appetite for emerging market currencies globally was subdued with investors avoiding big bets ahead of employment data in the United States, seen as an indicator to the direction of interest rates.

companyNews reuters.com

BRIEF-Genentech Announces Positive Interim Results From Phase 3 Study Evaluating Hemlibra

* GENENTECH-POSITIVE INTERIM RESULTS FROM PHASE III EVALUATING HEMLIBRA DOSED ONCE EVERY FOUR WEEKS IN ADULTS AND ADOLESCENTS WITH HEMOPHILIA A

companyNews reuters.com

Roche drug cocktail doubles chance of holding lung cancer at bay

ZURICH, Dec 7 (Reuters) - Adding Roche's immunotherapy Tecentriq to older drugs doubled the percentage of lung cancer patients who survived a year without their disease advancing, an outcome some experts labeled unprecedented.

businessNews reuters.com

Asia shares hover near 2-month low as growth, U.S. policy risks weigh

TOKYO (Reuters) - Asian shares hovered near two-month lows on Thursday as softer oil and copper prices and uncertainty over U.S. policy kept many investors on the sidelines, even as some high-tech bellwethers bounced back after a searing sell-off.

companyNews reuters.com

GLOBAL MARKETS-Asia shares hover near 2-mth low as growth, US policy risks weigh

* Ex-Japan Asia little changed despite rebound in some tech names

businessNews reuters.com

Asia shares hover near two-month low as growth, U.S. policy risks sap sentiment

TOKYO (Reuters) - Asian shares held close to a two-month low on Thursday as softer oil and copper as well as U.S. policy uncertainty kept sentiment in check, while high-tech stocks struggled to recover after a searing sell-off.

companyNews reuters.com

GLOBAL MARKETS-Asia shares hover near 2-mth low as growth, US policy risks sap sentiment

TOKYO, Dec 7 (Reuters) - Asian shares held close to a two-month low on Thursday as softer oil and copper as well as U.S. policy uncertainty kept sentiment in check, while high-tech stocks struggled to recover after a searing sell-off.

healthNews reuters.com

Knee surgery outcomes linked with education level

(Reuters Health) - Patients who live in low-income communities and lack a college education may have worse pain after knee replacement surgery than their more educated neighbors, a recent study suggests.

Hormones nytimes.com

Birth Control Pills Still Linked to Breast Cancer, Study Finds

Women using birth control pills and I.U.D.s that release hormones face a higher risk than those using methods without hormones, scientists in Denmark reported.

healthNews reuters.com

Study confirms higher breast cancer risk with hormone-based contraception

(Reuters Health) - Women who currently use or recently used hormone-based contraception face a 20 percent higher risk of breast cancer, although the overall risk for most women is relatively low, a new study of 1.8 million women in Denmark has concluded.

Books and Literature nytimes.com

Paris Review Editor Resigns Amid Inquiry Into His Conduct with Women

Lorin Stein apologized in letters he sent the board Wednesday, saying his behavior had been hurtful and degrading.

healthNews reuters.com

U.S. healthcare spending growth slowed in 2016

(Reuters) - Growth in healthcare spending in the United States slowed in 2016 following two years of expansion under the Affordable Care Act, a government health agency reported on Wednesday.

healthNews reuters.com

Home births in rural areas just as safe as in cities

(Reuters Health) - Home births may not be more dangerous for healthy rural mothers than for their urban counterparts, a recent U.S. study suggests.

Weinstein, Harvey nytimes.com

Harvey Weinstein and His Former Businesses Are Sued by Six Women in Class Action

In the lawsuit, the plaintiffs claim Miramax and The Weinstein Company worked to cover-up Mr. Weinstein’s “widespread sexual harassment and assault.”

companyNews reuters.com

BRIEF-Novartis Says Premenopausal Women Taking Kisqali Benefited For Longer Time Until Health-Related QOL Deterioration

* NOVARTIS KISQALI IS FIRST AND ONLY CDK4/6 INHIBITOR TO SHOW SUPERIOR MEDIAN PFS COMPARED TO ORAL ENDOCRINE THERAPY AS FIRST-LINE TREATMENT IN A PROSPECTIVE, RANDOMIZED PHASE III TRIAL DEDICATED TO PREMENOPAUSAL WOMEN WITH HR+/HER2- ADVANCED BREAST CANCER

healthNews reuters.com

Roche to seize leap-frog opportunity in lung cancer

LONDON (Reuters) - After lagging rivals in cancer immunotherapies, Swiss drugmaker Roche hopes to leap-frog into the lead in the biggest market, tackling previously untreated lung cancer.

companyNews reuters.com

UPDATE 1-Roche to seize leap-frog opportunity in lung cancer

* Roche CEO sees shake-out in crowded cancer R&D field (Adds sales forecasts, further details)

environmentNews reuters.com

Global warming may be more severe than expected by 2100: study

OSLO (Reuters) - World temperatures could rise 15 percent more than expected this century, obliging governments to make deeper cuts in greenhouse gas emissions to limit global warming, scientists said on Wednesday.

United States Politics and Government nytimes.com

Democratic Women in Senate Call on Al Franken to Resign

In a coordinated campaign, at least a half dozen Democratic women in the Senate called on their colleague, Senator Al Franken of Minnesota, to resign.

healthNews reuters.com

Kids aren’t protecting themselves against STDs during oral sex

(Reuters Health) - Adolescents and young adults regularly engage in oral sex but seldom use condoms to prevent the spread of sexually transmitted diseases, new research shows.

cnn.com

Opinion: Time magazine has sided with women over the misogynist-in-chief

A little over a year ago, despite a swirl of sexual assault allegations against him and a track record of misogyny, Donald Trump beat the woman many hoped would make it to the White House -- not only to the presidency, but to the title of Time magazine's Person of the Year. This year, it is the President who has to get in line.

healthNews reuters.com

FDA proposes drug development guidance for rare pediatric diseases

(Reuters) - The U.S. Food and Drug Administration issued a draft guidance on Wednesday to simplify the procedure of developing drugs for rare pediatric disorders, such as Gaucher's disease, by eliminating the need for certain trials and minimizing patient enrollment.

companyNews reuters.com

GLOBAL MARKETS-Yields fall, stocks choppy as risk appetite wanes

* U.S, German bond yields fall as investors move to safe assets

PersonalFinance reuters.com

Study abroad appeals to more U.S. college students, but costs can mount

CHICAGO (Reuters) - While most college seniors are still hoping to land a good job after graduation, Kelsey Berg is set.

healthNews reuters.com

Sign-ups pick up in week five of 2018 Obamacare open enrollment - U.S.

WASHINGTON (Reuters) - The number of people signing up for 2018 Obamacare plans picked up significantly during the fifth week of open enrollment, a U.S. government agency reported on Wednesday, but the number of people signed up for such plans appears to be falling short of last year's numbers with just over a week of enrollment left.

healthNews reuters.com

Myanmar's opium crop plummets, but no victory over Asia's narco-boom: U.N.

BANGKOK (Reuters) - A "dramatic" drop in opium cultivation in Myanmar underscored a regional boom in demand for illegal synthetic drugs such as methamphetamine, which many Asian countries are struggling to combat, a senior U.N. official said on Wednesday.

cnn.com

Balding, premature graying tied to higher heart disease risk

Male-pattern baldness and premature greying are associated with a greater risk of heart disease before the age of 40 than obesity, according to a new study from India. Does this mean that doctors should be screening our hairline alongside traditional risk factors such as our weight and blood pressure?

companyNews reuters.com

BRIEF-Glaxosmithkline Says ‍New Data From Phase III Clinical Study Supports Safety And Efficacy

* ‍NEW DATA FROM A PHASE III CLINICAL STUDY SUPPORTS SAFETY AND EFFICACY OF SHINGRIX IN PREVENTING SHINGLES​

businessNews reuters.com

Asia stocks hit 2-month low as risk sentiment sours broadly

TOKYO (Reuters) - Asian stocks slipped across the board on Wednesday as various factors including weaker metals prices and monetary policy concerns in China soured investor risk sentiment.

companyNews reuters.com

GLOBAL MARKETS-Asia stocks hit 2-mth low as risk sentiment sours broadly

* Nikkei drops 2 pct, copper slide hits non-ferrous metal sector

entertainmentNews reuters.com

Johnny Hallyday, 'French Elvis', dies at 74 after cancer

PARIS (Reuters) - Johnny Hallyday, whose death at 74 was announced by his wife and the French president on Wednesday, was a rock and roll giant in his native France and survived drug use, family strife and near-death episodes to strut the stage for more than fifty years.

entertainmentNews reuters.com

French rocker Johnny Hallyday dies at 74 after battle with cancer

PARIS (Reuters) - Johnny Hallyday, a singer known as the "French Elvis" whose cowboy swagger and gravelly voice helped popularize rock 'n roll in his country, has died at 74 after a battle with cancer, the office of the French president said on Wednesday.

United States Politics and Government nytimes.com

Bannon Finds New Fight Backing Roy Moore, but Risks Are High

The former White House strategist delivered a plea to elect Mr. Moore on Tuesday at a rally in southern Alabama.

entertainmentNews reuters.com

French singer Johnny Hallyday dies at 74 after battle with cancer

PARIS (Reuters) - Johnny Hallyday, a singer known as the "French Elvis" who helped popularize rock 'n roll in his country, has died at 74 after a battle with cancer, the office of the French president said on Wednesday.

healthNews reuters.com

GSK, other drugmakers bet on post-Brexit UK science

LONDON (Reuters) - Britain won a vote of confidence from its economically important life sciences sector on Wednesday as five drug companies committed to invest in the country under the government's industrial strategy plans after Brexit.

healthNews reuters.com

Australian watchdog takes GlaxoSmithKline, Novartis units to court

(Reuters) - The Australian Competition and Consumer Commission (ACCC) on Wednesday said it is taking local units of GlaxoSmithKline and Swiss healthcare company Novartis to court over false or misleading representations in the marketing of pain relief products.

healthNews reuters.com

Consistently lower cancer survival rates for black patients in U.S.

(Reuters Health) - Whether it's colon cancer, breast cancer, or ovarian cancer, survival rates in the U.S. are lower for black people than for white people, three new studies show.

healthNews reuters.com

Brazil, U.S. identify molecule to help fight citrus greening disease

SAO PAULO (Reuters) - Researchers have identified the molecule that attracts the insect that transmits citrus greening disease, a development expected to help farmers control a plague that has destroyed trees in growing regions of Brazil and the United States.

healthNews reuters.com

Paraguay Congress legalizes planting of medical marijuana

ASUNCION (Reuters) - Paraguay's Congress passed a bill on Tuesday creating a state-sponsored system to import marijuana seeds and grow the plant for medical uses, a decision that followed other countries in Latin America.

healthNews reuters.com

Eating almonds with chocolate may lower cholesterol

(Reuters Health) - Overweight and obese people who eat almonds and chocolate every day may have lower cholesterol than their counterparts who don’t consume these foods, a recent experiment suggests.

healthNews reuters.com

Hospital patients are safe with substitute doctors

(Reuters Health) - Hospital patients’ survival rates don’t suffer when fill-in doctors substitute for the regular staff physicians, a U.S. study suggests.

Women & Power: A Manifesto (Book) nytimes.com

Books of The Times: From Ancient Myths to Modern Day, Women and the Struggle for Power

In “Women & Power: A Manifesto,” the Cambridge classicist Mary Beard describes the scale of the problem and suggests some exciting remedies.

healthNews reuters.com

Women get mixed messages about sexuality after childbirth

(Reuters Health) - Women receive mixed messages about the ways giving birth may affect their sex lives, according to a new report.

healthNews reuters.com

FDA approves Novo Nordisk diabetes drug Ozempic

(Reuters) - The U.S. Food and Drug Administration on Tuesday approved Novo Nordisk A/S's diabetes drug Ozempic, setting the stage for a heated competitive battle with Eli Lilly & Co's Trulicity.

Women and Girls nytimes.com

Reckoning on Sexual Misconduct Divides Women Over How Harsh Judgment Must Be

As allegations of men’s misbehavior fuel a broader conversation, a zero-tolerance attitude has evolved into discussions about what is acceptable, due process and generational differences.

healthNews reuters.com

Galectin slumps after NASH drug misses main goal of mid-stage trial

(Reuters) - Galectin Therapeutics Inc said its drug for the complex progressive fatty liver disease NASH led to some clinically meaningful results in patients with cirrhosis, but failed to achieve the main goal of a mid-stage trial, sending its shares plunging 48 percent on Tuesday.

healthNews reuters.com

Shire in deal to develop a new way to administer hemophilia drug

(Reuters) - Shire Plc said on Tuesday it had partnered with a California-based company to develop a new way to administer a drug to treat hemophilia A.

healthNews reuters.com

Galectin says NASH drug misses main goal of midstage trial

(Reuters) - Galectin Therapeutics Inc said on Tuesday its experimental drug for the complex progressive fatty liver disease NASH led to some clinically meaningful results in patients with cirrhosis, but failed to achieve the main goal of a midstage trial.

healthNews reuters.com

Philippines halts sale of dengue vaccine as Sanofi downplays risk

MANILA/LONDON (Reuters) - The Philippines has ordered French drugmaker Sanofi to stop the sale, distribution and marketing of its Dengvaxia dengue vaccine in the country after the company last week warned it could worsen the disease in some cases.

cnn.com

Dodd-Frank rollbacks put America at risk

healthNews reuters.com

WHO backs Philippines suspension of Sanofi's dengue vaccine

GENEVA (Reuters) - The World Health Organization supported a decision by the Philippines Department of Health on Tuesday to suspend vaccinations with Sanofi's dengue drug Dengvaxia, the WHO said in a statement.

businessNews reuters.com

U.S. investors overweight in stocks despite market fears: study

NEW YORK (Reuters) - Three out of four U.S. investors age 40 and older worry about a correction that will eventually end the long-running bull market in stocks, yet most refuse to head for the exits.

cnn.com

These are the women who could elect Roy Moore

If Republican Roy Moore wins next week's Senate special election in Alabama, it will be largely because of his support among women.

scienceNews reuters.com

Arctic sea ice melt to exacerbate California droughts: study

WASHINGTON (Reuters) - Melting Arctic sea ice could render sun-soaked California vulnerable to a recurrence of the severe drought suffered in recent years as it is likely to cause high pressure systems that push away rain-bearing storms, a study released on Tuesday said.

cnn.com

Smokers 7 times more likely to use marijuana daily, study says

Smoking cigarettes and daily use of cannabis are strongly linked in the United States, research says. Smokers, overall, are seven times more likely to use pot daily than non-smokers, according to a study recently published in the American Journal of Public Health.

companyNews reuters.com

Severe dengue vaccine risk in uninfected '2 in a 1,000' -Sanofi

LONDON, Dec 5 (Reuters) - French drugmaker Sanofi said on Tuesday the risk of severe dengue occurring in previously uninfected people given its Dengvaxia dengue vaccine was around two in 1,000 and these individuals recovered with treatment.

cnn.com

Opinion: Trump's women are complicit

I am dying to know what's really going on with all the President's women. I vividly remember Ivanka Trump, in her blush-colored dress, introducing her father at the Republican National Convention in Cleveland. So compelling, so savvy -- her dress cost $138 -- and so independent.

cnn.com

Cocaine kills as many blacks as opioids kill whites, study finds

The American opioid crisis is only part of an overall drug abuse emergency. Cocaine-related overdose deaths among non-Hispanic blacks are on par with overdose deaths caused by heroin and prescription opioids among whites, according to a study published Monday in the medical journal Annals of Internal Medicine.

New York Times Neediest Cases Fund nytimes.com

The Neediest Cases Fund: At 76, Studying Social Work After Reaching for a Helping Hand

Selwyn Allen, a longtime carpenter, fell behind on his rent while fighting bladder cancer. Now he’s seeking to make a late-in-life career change.

healthNews reuters.com

Court-mandated opioid rehab rarely meets medical standards

(Reuters Health) - Fewer than one in 20 people with opioid addiction problems who are ordered into rehab programs by the courts receive methadone or buprenorphine, two drugs doctors consider the best treatment option, a U.S. study suggests.

healthNews reuters.com

Montana sues OxyContin maker Purdue over opioid epidemic

(Reuters) - Montana has sued OxyContin maker Purdue Pharma LP, withdrawing from a multistate investigation by attorneys general into opioid manufacturers' marketing practices and joining a growing list of states that have broken off to pursue individual lawsuits.

healthNews reuters.com

Trouble mounts for Sanofi dengue vaccine over safety concerns

(Reuters) - The World Health Organization said on Monday it hopes to review safety data on Sanofi's dengue vaccine this month, while the Philippines ordered an investigation of its now suspended massive immunization program after the French drugmaker said it could actually worsen the disease in some cases.

healthNews reuters.com

Tattooed wish for withholding treatment not good enough, doctors say

(Reuters Health) - Consumers are often told, "Put it in writing." But in the case of a hospitalized Florida man facing death, displaying his wish by having it tattooed on his chest wasn't good enough.

healthNews reuters.com

Healthcare prices hard to find online

Reuters Health - Consumers who search online for prices of common medical procedures may be disappointed by what they find, a U.S. study suggests.

healthNews reuters.com

Sanofi says monitoring outcomes of ongoing dengue vaccination schemes

PARIS (Reuters) - Sanofi on Monday said it was monitoring outcomes of ongoing public programs involving its dengue vaccine, Dengvaxia, following the launch of a probe in the Philippines.

Diabetes nytimes.com

Take a Number: Two Hidden Cancer Causes: Diabetes and Obesity

The conditions played a role in nearly 800,000 cases of cancer worldwide in 2012, researchers reported.

healthNews reuters.com

WHO reviewing data on Sanofi dengue vaccine, urges limited use

GENEVA (Reuters) - The World Health Organization (WHO) said on Monday it hoped to conduct a "full review" by year-end of data on Sanofi's dengue vaccine Dengvaxia.

healthNews reuters.com

Poor regulation, dodgy pills spur plan for African drugs agency

LONDON (Reuters) - Last July, Ugandan officials seized fake versions of the cancer drug Avastin on sale in Kampala, revealing only the tip of an iceberg of bogus medicines found all too often in Africa.

healthNews reuters.com

Brazil recommends restrictions on Sanofi dengue vaccine

BRASILIA (Reuters) - The Brazilian government said on Monday it has suggested restrictions on the use of a dengue vaccine that has been suspended elsewhere after French drug company Sanofi SA said it could worsen the disease in some cases.

healthNews reuters.com

Therapix expects to have results of Tourette's drug trial by end of first quarter

TEL AVIV (Reuters) - Israel's Therapix Biosciences said on Monday it expects by the end of March to have the results from its mid-stage trial of a cannabinoid-based drug for treating Tourette's syndrome which could be worth billions of dollars in revenues.

companyNews reuters.com

BRIEF-Ultragenyx And Kyowa Kirin Announce Positive 48-Week Data From Adult Phase 3 Study Of Burosumab In X-Linked Hypophosphatemia

* ULTRAGENYX AND KYOWA KIRIN ANNOUNCE POSITIVE 48-WEEK DATA FROM ADULT PHASE 3 STUDY OF BUROSUMAB (KRN23) IN X-LINKED HYPOPHOSPHATEMIA Source text for Eikon: Further company coverage:

companyNews reuters.com

BRIEF-Loxo Oncology Announces Updated Larotrectinib Pediatric Clinical Trial Data Demonstrating Continued Durability Of Response In TRK Fusion Cancers

* LOXO ONCOLOGY ANNOUNCES UPDATED LAROTRECTINIB PEDIATRIC CLINICAL TRIAL DATA DEMONSTRATING CONTINUED DURABILITY OF RESPONSE IN TRK FUSION CANCERS

healthNews reuters.com

Hungary's Richter says no link seen between Esmya drug and liver damage

BUDAPEST (Reuters) - Hungarian drugmaker Richter's clinical data for its uterine fibroid treatment Esmya indicate no demonstrable link with liver damage, the firm said on Monday.

Women and Girls nytimes.com

Women Line Up to Run for Office, Harnessing Their Outrage at Trump

The election of President Trump, the Women’s March and a flood of sexual assault charges against powerful men have combined to build a wave of political activism among women.

healthNews reuters.com

Denmark's Alk Abello suspends dividend to support North America investment

(Reuters) - Danish pharma company Alk Abello said on Monday it would invest 1 billion Danish crowns ($159 million) in its North America business, a move that is expected put a lid on earnings and revenue growth in the near term.

worldNews reuters.com

Risks grow for Rohingya in Bangladesh's teeming, squalid camps

(Reuters) - Bangladesh plans to allocate more land for camps housing Rohingya refugees as concerns grow over a possible outbreak of disease in crowded, makeshift settlements clustered at the country's southern tip.

healthNews reuters.com

Danish pharma company Alk Abello to invest 1 billion crowns in North America

(Reuters) - Danish pharma company Alk Abello said on Monday it would invest about 1 billion Danish crowns ($159.5 million) over the next three years to develop its North America business and said it expected earnings to be subdued during this period.

companyNews reuters.com

Roche's Foundation Medicine wins FDA blessing for new cancer test

ZURICH, Dec 4 (Reuters) - Roche on Monday said its Foundation Medicine unit won U.S. Food and Drug Administration (FDA) approval for a test to help doctors understand the genetic profile of patients' tumours and guide them to effective therapies.

healthNews reuters.com

Sanofi says no reported deaths in Philippines related to dengue vaccine

MANILA (Reuters) - There have been no reported deaths in the Philippines related to a suspended dengue vaccine made by Sanofi, an official from the pharmaceutical company said on Monday.

cnn.com

Women will host CBS and NBC morning shows this week

Two network news morning shows, two all-women lineups.

cnn.com

Alabama women divided on Moore

Republican women are divided on Roy Moore in the Alabama Senate race following sexual abuse allegations against Moore.

healthNews reuters.com

Cholera could resurge in Yemen due to lack of aid, fuel: WHO

GENEVA (Reuters) - Another wave of cholera could strike Yemen, where a Saudi-led coalition blockade has cut off fuel for hospitals, water pumps and vital aid supplies for starving children, the World Health Organization (WHO) said on Sunday.

healthNews reuters.com

Philippine president vows to get to the bottom of dengue vaccine 'health scam'

MANILA (Reuters) - The office of the Philippine president on Sunday vowed to hold accountable those responsible for a suspended dengue immunization program, which it said placed thousands of lives at risk.

healthNews reuters.com

U.S. Senate tax bill accomplishes major Obamacare repeal goal

WASHINGTON (Reuters) - The sweeping tax overhaul that passed the U.S. Senate on Saturday contains the Republicans' biggest blow yet to former President Barack Obama's healthcare law, repealing the requirement that all Americans obtain health insurance.

vis-dispatch nytimes.com

A Man Among Female Leaders: ‘The Risk of Mansplaining Is Very High’

A Times reporter shadows a male speaker at a summit meeting of female political leaders in Iceland, the most gender-egalitarian country in the world.

Women and Girls nytimes.com

Opinion: The Cost of Devaluing Women

We all lose because of the biases of Wall Street and Silicon Valley.

cnn.com

Feds: Women tested ricin recipe on retirement community

The cupboard above the stove in Betty Miller's retirement apartment contained bottles labeled "apple seed," "cherry seed," "castor beans," and "ricin," the FBI says.

Immigration and Emigration nytimes.com

Deported Repeatedly, Man Is Sentenced to 35 Years for Attacks on 2 Oregon Women

The man, Sergio Jose Martinez, a Mexican immigrant, attacked two women on July 24. He received national attention after Attorney General Jeff Sessions highlighted his case.

Kutin, Naomi nytimes.com

Character Study: Meet ‘Supergirl,’ the World’s Strongest Teenager

Naomi Kutin, 16, is an Orthodox Jewish girl from New Jersey with a knack for setting powerlifting records.

businessNews reuters.com

Fear of missing out keeps investors in stocks despite risks

NEW YORK, (Reuters) - Wall Street's fear of missing out on a relentless rally appears to be trumping rising political risk in a high-stakes December in Washington.

healthNews reuters.com

First U.S. birth for woman with transplanted uterus occurs in Texas

(Reuters) - For the first time in the United States, a woman with a transplanted uterus gave birth, officials at a Dallas hospital said on Friday.

healthNews reuters.com

Patients have different hospital outcomes when regular doctors see them

(Reuters Health) - Many outcomes for hospital patients – including how long they stay and their survival odds after they go home – may depend on whether they’re cared for by their primary care physician or another type of doctor, a U.S. study suggests.

healthNews reuters.com

FDA approves heart protection claims for Amgen cholesterol drug

(Reuters) - Amgen Inc can now promote the ability of its potent but expensive cholesterol drug to reduce the risk of heart attacks and strokes, after U.S. health regulators approved adding those benefits to the medicine's prescribing label, the company said on Friday.

healthNews reuters.com

Sanofi ends development of Clostridium difficile vaccine

(Reuters) - Pharmaceutical company Sanofi SA said on Friday that it had ended development of an experimental vaccine for Clostridium difficile infection, after an early look at late-stage trial results indicated a low probability for success.

cnn.com

OPinion: Women don't need a man-to-man between Jimmy Kimmel and Roy Moore

Let's get one thing straight, Jimmy Kimmel and Roy Moore: The last thing American women want or need is for you two to defend our honor in some kind of retrograde battle.

healthNews reuters.com

Fetuses grow differently in obese women

(Reuters Health) - Obese pregnant women who don’t have serious medical problems are still more likely to have unusually large babies than mothers who aren’t obese, a recent study suggests.

businessNews reuters.com

Political risk on Wall Street? Buy the dip!

SAN FRANCISCO (Reuters) - An abrupt stock selloff on Friday, sparked by a report that magnified concerns about President Donald Trump's potential links with Russia, prompted Wall Street's favorite reaction in recent months: "Buy the dip."

healthNews reuters.com

Nestle, Stada prepare rival bids for Germany's Merck consumer health: sources

LONDON/FRANKFURT (Reuters) - Swiss food giant Nestle and the private equity owners of German drug firm Stada are both preparing tentative bids for Merck KgaA's consumer health unit, several sources told Reuters.

healthNews reuters.com

Cuba battling medicine shortages in wake of cash crunch

HAVANA (Reuters) - Cuba is working on fixing chronic medicine shortages that started appearing a year ago due to its cash crunch, health officials said in an article published late on Thursday in ruling Communist Party newspaper Granma.

companyNews reuters.com

REFILE-BRIEF-FDA Says Approves Mylan GmbH's Ogivri As First Biosimilar For Treatment Of Certain Breast, Stomach Cancers

* FDA SAYS APPROVES MYLAN GMBH'S OGIVRI AS A FIRST BIOSIMILAR FOR TREATMENT OF CERTAIN BREAST AND STOMACH CANCERS

healthNews reuters.com

FDA OKs Mylan's biosimilar of Roche cancer drug Herceptin

(Reuters) - The U.S. Food and Drug Administration on Friday approved Mylan NV's biosimilar of Herceptin, Roche's blockbuster treatment for breast cancer, making it the second copycat drug for cancer approved in the United States.

healthNews reuters.com

Smoking, drinking worsen prognosis for head and neck cancers

(Reuters Health) - People with head and neck cancers who smoke and drink are much more likely to die with these tumors than nonsmokers and teetotalers, a recent study suggests.

healthNews reuters.com

Doctors rarely discuss end-of-life care for chronic lung conditions

(Reuters Health) - Though most people suffering from chronic respiratory diseases want to discuss their preferences for end-of-life care with medical providers, they seldom do, a new review of past research suggests.

healthNews reuters.com

FDA approves Mylan's biosimilar of Roche's cancer drug Herceptin

(Reuters) - The U.S. Food and Drug Administration on Friday approved Mylan NV's biosimilar version of Roche's blockbuster breast cancer treatment Herceptin.